The Life Sciences sector includes companies involved in biopharmaceuticals, medical manufacturing and distribution, and bio products.
Gemina Labs is a biosensor and diagnostic company with a unique and transformative proprietary biochemistry that significantly improves the performance of human and animal testings, including COVID-19, Influenza and other viruses.
GeneTether Therapeutics is an innovative genetic medicines company focused on creating best-in-class gene editing therapies based on our proprietary GeneTether™ platform. Our platform is designed to increase the efficiency of genome editing technologies, including CRISPR-Cas, TALENs, and ZFNs. We use a proprietary method to “tether” donor DNA templates to the genome editing complex, making the template readily available for use during the genome editing repair stage.
Global Health Clinics operates a two-part system of customer lead generation and conversion, through its network of pavilions and the ownership and operation of five medical clinics that aim to connect Canadians with ACMPR license producers by advancing the understanding of medical cannabis and its applications, and the provision of related services and products for patients suffering from illness from which they may find relief with medical cannabis, including facilitating access to qualified health care practitioners, independent medical cannabis evaluations and related advice. Through its pavilions, the company is developing a substantive consumer database of persons interested in both medicinal and recreational use
Green Scientific Labs Holdings Inc. is a leading cannabis and hemp testing laboratory that currently operates one testing lab facility in Florida which provides analytical testing services for state licensed cannabis and hemp growers, product formulators, processors, distributors and retailers. GSL provides industry-leading analysis and testing to the cannabis and hemp industry, under ISO-17025:2017 guidelines, to ensure consumers know in the composition of cannabis and hemp they ingest and to help maximize the quality of its client’s products through research, development and standardization.
Green Thumb Industries (GTI), a national cannabis consumer packaged goods company and retailer, is dedicated to providing dignified access to cannabis while giving back to the communities in which they serve. GTI manufactures and distributes a portfolio of branded cannabis products including &Shine, Beboe, Dogwalkers, Dr. Solomon’s, Good Green, incredibles, and RYTHM. The Company also owns and operates a rapidly growing national chain of retail cannabis stores called RISE. Headquartered in Chicago, Illinois, GTI has 20 manufacturing facilities, 98 open retail locations and operations across 14 U.S. markets. Established in 2014, GTI employs approximately 4,600 people and serves millions of patients and customers each year.
Investor Note: In addition to the 211,727,726 Subordinate Voting Shares that are listed and trading, there are 24,437,300 shares reserved specifically for issuance pursuant to the conversion rights attached to the Super Voting Shares and Multiple Voting Shares that are issued and outstanding but not listed. The total number of equity shares assuming all are converted into the listed class would be 236,165,026.
Greenrise is a Canadian incorporated publicly traded investment holding company focused on investing in the cannabis industry in Germany.
Greenway Greenhouse Cannabis Corporation (“Greenway”) is a federally licensed cultivator and processor of high quality greenhouse cannabis through lean, high-margin cultivation methods for the Canadian cannabis marketplace. Greenway operates out of two facilities, its growing facility based out of Leamington, Ontario and its headquartered in Kingsville, Ontario. Greenway leverages its agriculture and cannabis expertise in its aspiration to be a leading cannabis cultivator in Canada. In Canada, Greenway sells dried bud cannabis product to provincially authorized retailers, distributors, and federally licensed entities in accordance with the Cannabis Act (Canada).
Grown Rogue International Inc. (CSE: GRIN | OTC: GRUSF) is a craft cannabis company operating in Oregon, Michigan, Minnesota, Maryland, and New Jersey, focused on delighting customers with premium flower and flower-derived products at fair prices. The Company's roots are in Southern Oregon, where it has proven its capabilities in the highly competitive and discerning Oregon market. The Company's passion for quality product and value, combined with a disciplined approach to growth, prioritizes profitability and return on capital without sacrificing quality. The Company's strategy is to pursue capital efficient methods to expand into new markets, bringing craft-quality product at fair prices to more consumers. The Company also continues to make modest investments to improve outdoor craft cultivation capabilities in preparation for eventual interstate commerce. For more information, visit www.grownrogue.com.
Grown Rogue has two classes of equity shares: subordinate voting shares (“SVS”) and multiple voting shares (“MVS”). SVS are publicly traded on the CSE and are entitled to one vote. MVS are not publicly traded, can convert to SVS at a ratio of 1 MVS to 1,000 SVS, and are entitled to 1,000 votes per MVS.
There are 143,421,865 SVS outstanding and 75,194.941 MVS convertible to 75,194,941 outstanding for a total outstanding SVS of 218,616,806 on an as-converted basis.
Please see Schedule “A” to Grown Rogue’s management information circular dated May 14, 2024 for a further description of the SVS and MVS.
A Quick Serve Restaurant ("QSR") and Consumer Packaged Goods ("CPG") company bringing delicious foods and retail brands to customers. We acquire and grow emerging brands that have great tasting food managed by great people (founders/owners) that need strategic, operational and financial guidance to grow and scale their businesses.
HAVN Life Sciences Inc. is a biotechnology company pursuing standardized extraction of psychedelic compounds for the creation of APIs and the development of natural health products and innovative therapies to support brain health. Through its research division, HAVN Labs, the company has developed an end-to-end supply chain of standardized, naturally derived psychedelic compounds for research that will define the future of modern medicine. With its new line of natural health products, the company offers a full range of high-quality mushroom and plant extracts that help boost immune function, reduce inflammation and support a healthy lifestyle. Learn more at: havnlife.com and follow us on Facebook, Twitter, Instagram and Youtube.
